The global digital
pathology market size is expected to reach USD 887.7 million by
2025, according to a new report by Grand View Research, Inc., exhibiting a CAGR
of 12.0% during the forecast period. Growing prevalence of chronic diseases
such as cancer is one of the key factors stimulating market growth. As a
consequence of high prevalence of cancer, pathologists require specific data
that facilitates personalization of therapies for patients. Thereby, digital
pathology is increasingly being preferred by pathologists as it accelerates the
rate of diagnosis, increases diagnostic accuracy, and provides therapeutic
recommendations to improve patient outcomes. Pathologists and researchers
require highly efficient biomarker quantification tool for efficient cancer
diagnosis, thus augmenting the demand for automatic image analysis, which helps
in molecular, functional, and genetic characterization of tumors.
Benefits associated with digital pathology is
responsible for the broadening growth potential of the market. It also
facilitates histological slide sharing and eliminates issues pertaining to
sharing sample of live cells and degradation of these samples. It also enables
a pathologist to share sample specimen images, thus eliminating the need for
transportation of slides. Significant increase in the number of cancer cases
has resulted in discordance in ratio of patients to that of pathologists.
Shortage of pathologists owing to poor recruitment and significant increase in
the complexity of diagnostics has raised the demand for digital pathology
further for evaluation of chronic diseases.
Browse full research report on Digital Pathology Market: https://www.grandviewresearch.com/industry-analysis/digital-pathology-systems-market
Further
key findings From the report suggest:
- Whole slide imaging accounted for the largest share of the market
in 2016 owing to increasing awareness regarding associated advantages such
as automated scanning
- The telepathology segment is anticipated to register a moderate
growth rate. This type of technology offers various benefits such as
immediate access to offsite pathologists and subspecialty pathologists
- The academic research segment dominated the market in terms of
application in 2016, owing to factors such as growing usage of digital
pathology in various research procedures such as biomarker profiling and
tumor morphological study
- Disease diagnosis is likely to post a remarkable CAGR during the
forecast period owing to factors such as increasing incidence of chronic
diseases such as diabetes and cancer
- In 2016, North America held a substantial share owing to growing
prevalence of chronic diseases due to unhealthy lifestyles and high stress
levels among population
- The Asia Pacific digital pathology market is projected to progress
at a significant CAGR during the same period owing to improving healthcare
systems, rising healthcare expenditure, and growing awareness.
Browse more reports of this category
by Grand View Research: https://www.grandviewresearch.com/industry/healthcare-it
Grand
View Research has segmented the global digital pathology market on the basis of
technology, application, end-use, and region:
Digital
Pathology Technology Outlook (Revenue, USD Million; Volume, ‘000 Units, 2014 -
2025)
- Whole Slide
Imaging
- Telepathology
- Static
- Dynamic
Digital
Pathology Application Outlook (Revenue, USD Million, 2014 - 2025)
- Drug
Discovery & Development
- Academic
Research
- Disease
Diagnosis
Digital
Pathology End-use Outlook (Revenue, USD Million, 2014 - 2025)
- Hospitals
- Private
Clinics
- Diagnostic
Labs
- Research
Centers
Digital
Pathology Regional Outlook (Revenue, USD Million, 2014 - 2025)
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Italy
- Russia
- Spain
- Netherlands
- Switzerland
- Sweden
- Asia Pacific
- Japan
- China
- India
- Indonesia
- Thailand
- Australia
- South Korea
- Philippines
- Malaysia
- Singapore
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East
& Africa
- South Africa
- Saudi Arabia
- Turkey
- Iran
- United Arab
Emirates
- Israel
About Grand View
Research
Grand View Research, Inc. is a U.S. based market
research and consulting company, registered in the State of California and
headquartered in San Francisco. The company provides syndicated research
reports, customized research reports, and consulting services. To help clients
make informed business decisions, we offer market intelligence studies ensuring
relevant and fact-based research across a range of industries, from technology
to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com
No comments:
Post a Comment